Atlas Trials

Savara Inc.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Savara Inc.

RecordFirmDate
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP). (NCT06431776)Savara Inc.2025-10-22
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (NCT04544293)Savara Inc.2021-05-19
Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection (NCT03597347)Savara Inc.2019-06-20
Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (NCT03482752)Savara Inc.2018-04-16
Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection (NCT03421743)Savara Inc.2018-03-01
AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis (NCT03181932)Savara Inc.2017-09-20

Track Savara Inc. automatically

Every clearance here is in the API, with alerts when new ones post.